<DOC>
	<DOCNO>NCT02469753</DOCNO>
	<brief_summary>Ankylosing spondylitis ( AS ) frequent chronic inflammatory rheumatic disease affect axial skeleton , start sacroiliac joint spread spine patient . Non-steroidal anti-inflammatory drug ( NSAIDs ) primary treatment AS . Even use anti-TNF agent demonstrate good clinical efficacy control inflammation , contrast condition rheumatoid arthritis psoriatic arthritis , anti-TNF treatment fail demonstrate benefit structural progression AS , data even suggest may accelerate formation syndesmophytes seem independent process TNF . Conversely , NSAIDs inhibit ossification phenomenon independently anti-inflammatory property , owe specific action bone formation via prostaglandin inhibition . Several feature suggest continuous NSAID therapy need , addition anti-TNF treatment , prevent syndesmophyte formation AS patient .</brief_summary>
	<brief_title>Interest Continuous Non-Steroidal Anti-Inflammatory Drug Treatment Ankylosing Spondylitis Patients Treated Anti-TNF Therapy Prevention Radiographic Outcomes</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Patients age 18 year old Patients fulfil 1984 modify New York criterion ankylose spondylitis : SA patient indication antiTNF treatment initiation accord French society Rheumatology guideline . Being affiliated health insurance system Having sign informed consent form ( late day inclusion examination require research ) Patients present another chronic systemic inflammatory disorder , different ankylose spondylitis . Patients present contraindication treatment NSAIDs . Patient daily corticosteroid treatment dosage â‰¥ 10 mg/day Pregnant breastfeed woman Contraindication MRI ( pacemaker , aneurysm clip , artificial heart valve , ear implant , metal fragment foreign object eye , skin body , claustrophobia ) refuse undergo MRI Women refuse effective contraception method study duration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>NSAIDs</keyword>
	<keyword>Anti-TNF</keyword>
	<keyword>syndesmophytes</keyword>
	<keyword>mSASSS</keyword>
</DOC>